Stockscreener 앱 받기
2.075
1.19%
-0.025
전일 마감가:
$2.10
열려 있는:
$2.09
하루 거래량:
23,330
Relative Volume:
0.46
시가총액:
$81.25M
수익:
$57,000
순이익/손실:
$-32.14M
주가수익비율:
-3.2091
EPS:
-0.6466
순현금흐름:
$-27.58M
1주 성능:
+1.22%
1개월 성능:
+14.01%
6개월 성능:
-24.82%
1년 성능:
-25.36%
1일 변동 폭
$2.01
$2.13
1주일 범위
$1.95
$2.21
52주 변동 폭
$1.56
$3.95
Sera Prognostics Inc Stock (SERA) Company Profile
명칭
Sera Prognostics Inc
전화
(801) 990-0520
주소
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
2.075 | 80.28M | 57,000 | -32.14M | -27.58M | -0.6466 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 개시 | Jefferies | Buy |
| 2022-03-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | Oppenheimer | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
Sera Prognostics Inc 주식(SERA)의 최신 뉴스
Sera Prognostics Inc (SERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SERA|Sera Prognostics Inc|Price:2.100|Chg%:+0.050 - TradingKey
Sera Prognostics Inc (SERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sera Prognostics Inc (SERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
Sera Prognostics Inc (SERA) Income Statement - TradingKey
Sera Prognostics Inc (SERA) Cash Flow - TradingKey
SERA|Sera Prognostics Inc|Price:2.050|Chg%:-0.120 - TradingKey
Sera Prognostics Inc (SERA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sera Prognostics Inc. (SERA) Q1 2026 Earnings: In-Line Loss as Pre-Revenue Diagnostics Firm Continues DevelopmentPerformance Review - po-news-eg.net
Aberdeen Group plc's Strategic Acquisition of Sera Prognostics I - GuruFocus
Sera Prognostics study shows NICU admission cut in first births By Investing.com - Investing.com Nigeria
abrdn Group holds 7.21% of Sera Prognostics (SERA) stock - Stock Titan
Sera Prognostics Q1 2026 Earnings: EPS Matches Estimates, No Revenue, Stock Jumps 9%Earnings Volatility Report - dars.gov.et
Form 4 Sera Prognostics Inc For: 14 July By Investing.com - Investing.com South Africa
Sera Prognostics grants RSUs and options to director | SERA Insider Trading - Stock Titan
Sera Prognostics (SERA) director receives RSU and stock option grants - Stock Titan
Equity grants: Sera Prognostics (SERA) awards RSUs and options - Stock Titan
Sera Prognostics (SERA) grants RSUs and stock options to director Kim Kamdar - Stock Titan
Sera Prognostics (SERA) grants RSUs and options to director - Stock Titan
Sera Prognostics (SERA) awards RSUs and $1.97 stock options to director - Stock Titan
Sera Prognostics (SERA) grants new RSUs and stock options - Stock Titan
Sera Prognostics study shows NICU admission cut in first births - Investing.com
PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE - PR Newswire
Sera Prognostics Q1 2026 Earnings: In-Line Results as Preterm Birth Diagnostic Company Continues Pre-Revenue PhaseEarnings Miss Streak - DonanımHaber
Sera Prognostics Among 3 Intriguing Penny Stocks To Consider - simplywall.st
SERASera Prognostics Inc Options - Finviz
Director Mark Christopher Capone files Form 3 for Sera Prognostics (SERA) - Stock Titan
Sera Prognostics, Inc. Class A Actuals & Estimates (NASDAQ:SERA) - TradingView
Sera Prognostics adds former Myriad Genetics CEO to board By Investing.com - Investing.com South Africa
Sera Prognostics, Inc. Appoints Mark Capone as Class II Director and Member of Compensation Committee, Effective as of July 1, 2026 - marketscreener.com
Sera Prognostics adds former Myriad Genetics CEO to board - Investing.com
Sera Prognostics Adds Veteran Executive to Board - TipRanks
Mark Capone appointed to Sera Prognostics board, joins Compensation Committee - TradingView
Veteran diagnostics leader Mark Capone joins Sera Prognostics (NASDAQ: SERA) board - Stock Titan
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS - Nasdaq
Sera Prognostics (SERA) Edges Higher as Stock Tests Key Resistance LevelStop Run - dars.gov.et
Sera Prognostics, Inc.(NasdaqGM:SERA) added to Russell Microcap Value Benchmark Index - marketscreener.com
Sera Prognostics, Inc.(NasdaqGM: SERA) added to Russell 3000E Value Benchmark - marketscreener.com
Sera Prognostics, Inc. Class A Actuals & Estimates (BOATS:SERA) - TradingView
SERA Forecast — Price Target — Prediction for 2027 - TradingView
Sera Prognostics (SERA) loses 27% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Price to earnings forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Enterprise value to revenue forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Price to sales forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH - PR Newswire
Price to book forward of Sera Prognostics, Inc. – NASDAQ:SERA - TradingView
Enterprise value to EBIT forward of Sera Prognostics, Inc. – BOATS:SERA - TradingView
Illinois expands Medicaid coverage for preterm birth tests By Investing.com - Investing.com South Africa
Illinois expands Medicaid coverage for preterm birth tests - Investing.com UK
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY - PR Newswire
Sera Prognostics Inc (SERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sera Prognostics Inc 주식 (SERA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Aerts Austin | Chief Financial Officer |
Jun 11 '26 |
Sale |
2.01 |
2,037 |
4,094 |
301,190 |
| Lindgardt Zhenya | Chief Executive Officer |
Jun 11 '26 |
Sale |
2.01 |
6,990 |
14,050 |
865,009 |
| Inglis Tiffany Eul Davis | Chief Medical Officer |
Jun 11 '26 |
Sale |
2.01 |
362 |
728 |
92,075 |
| Jackson Benjamin | General Counsel |
Jun 11 '26 |
Sale |
2.01 |
2,179 |
4,380 |
161,756 |
1.04%
11.95%
자본화:
|
볼륨(24시간):